canada semaglutide patent As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics Hims & Hers to offer

The distinction that matters is whether GLP-1 receptor agonists cause a disproportionate loss of muscle relative to fat

Those with pre-existing mental health conditions may require closer monitoring and coordinated care between GP, diabetes specialists, and mental health professionals

Todays weight management options range from GLP-1 medications to bariatric procedures

That patient probably needs to be monitored much more closely and to think much more deeply about whether or not a GLP-1 is right for them, he said

Like Ozempic and Wegovy, it contains the active ingredient semaglutide

The impact of insulin-dependent diabetes on ventilatory control in the mouse